FDA Breast Density Reporting Requirements and Evidence-Based Medical Practice
JAMA · 13.05.2025 · 333 (18) · 1632
DOI: 10.1001/jama.2025.0001 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 13.05.2025. Verfasst von Christoph I Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Washington School of Medicine, Seattle, Washington. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
This JAMA Insights provides an evidence-based summary for discussing information about breast density with patients, including discussions that involve shared decision-making.
Autor:innen und Institutionen
- Department of Radiology, University of Washington School of Medicine, Seattle, Washington.
- Department of Health Systems & Population Health, University of Washington School of Public Health, Seattle, Washington.
- Fred Hutchinson Cancer Center, Seattle, Washington.
- Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
- UCLA National Clinician Scholars Program, Los Angeles, California.
Zitieren
APA
Lee, C. I., & Elmore, J. G. (2025). FDA Breast Density Reporting Requirements and Evidence-Based Medical Practice. JAMA, 333(18), 1632. https://doi.org/10.1001/jama.2025.0001
Vancouver
Lee CI, Elmore JG. FDA Breast Density Reporting Requirements and Evidence-Based Medical Practice. JAMA. 2025;333(18):1632. doi:10.1001/jama.2025.0001
BibTeX
@article{Lee2025,
author = {Lee, Christoph I and Elmore, Joann G},
title = {FDA Breast Density Reporting Requirements and Evidence-Based Medical Practice},
journal = {JAMA},
year = {2025},
volume = {333},
number = {18},
pages = {1632},
doi = {10.1001/jama.2025.0001}
}
EUVIMED